Shirish M. Gadgeel
0000-0001-5240-3811
Publication & Citation Trends
Publications
0 total
Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, 2026.3.0.
Cited by 1
Semantic Scholar
Clinicogenomic Characteristics and Treatment Outcomes of Patients With Advanced ALK -Rearranged Squamous and Adenosquamous Non–Small Cell Lung Cancers
Cited by 0
Semantic Scholar
COVID-19 in Patients With Gynecologic Cancer: A Report From the COVID-19 and Cancer Consortium
Cited by 0
Semantic Scholar
TAPISTRY: A Phase II Study of Atezolizumab in Patients with Tumor Mutational Burden–High Tumors
Cited by 0
Semantic Scholar
Landscape of Genomic Mechanisms of Resistance to Selective RET Inhibitors in RET-Altered Solid Tumors: Analysis of the RETgistry Global Consortium.
Cited by 1
Semantic Scholar
Final Efficacy and Safety Data From the Phase I/II ARROW Study of Pralsetinib in Patients With Advanced RET Fusion–Positive Non–Small Cell Lung Cancer
Cited by 0
Semantic Scholar
In silico evaluation of the interaction of P-gp and 3A4 substrates with the WEE1 inhibitor Debio 0123 and clinical application in the Debio 0123-104 combination trial with carboplatin and etoposide.
Cited by 0
Semantic Scholar
Research Topics
Lung Cancer Treatments and Mutations
(463)
Lung Cancer Research Studies
(194)
Colorectal Cancer Treatments and Studies
(139)
Lung Cancer Diagnosis and Treatment
(132)
Cancer Genomics and Diagnostics
(129)
Affiliations
University of Maryland, Baltimore
Fox Chase Cancer Center
Roswell Park Comprehensive Cancer Center
Ford Motor Company (United States)
University of Maryland Medical Center